Schedule & Agenda

World-class education program, delivered in person in San Diego, CA

Explore the BIO 2022 Programming below.

BIO International Convention
Date
  • Show All
Time
  • Show All
  • Show All
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Sessions
BIO International Convention
Jump to Day
93 Results
Monday, June 13
1:00 PM - 2:00 PM (PDT)
What do biotech companies need to consider as they develop the next breakthrough treatment for…
Session Room 2
When Vividion examined the next steps for their company, an IPO was the path forward. Until one day…
Session Room 3
Pre-POC biotechs, including platform companies, are increasingly recognizing the importance of…
Session Room 6C
In late 2020, FDA announced that it had awarded four grants to researchers to examine the use of…
Session Room 5A
The biotechnology industry touches every part of our lives, from the medicines helping patients,…
Session Room 7B
Whether you are public or private, raising capital or not, in-person or on-line, join us for a…
Session Room 6D
One silver lining of the COVID-19 pandemic is the boundless innovation it has sparked in the…
Session Room 8
In the Business Development and Transactions community, we often focus on the big splashy asset or …
Session Room 6F
Conducting a successful clinical trial for orphan and rare diseases presents unique challenges…
Session Room 11A
2:15 PM - 3:15 PM (PDT)
While there are many other sectors that are the focus of carbon-intensity reduction, the healthcare…
Session Room 7B
Individualized antisense oglionucleotide (ASO) technology is increasingly capturing the attention…
Session Room 11A
ORBIS has demonstrated success and seems to function as a forum for other global regulators to…
Session Room 6C
Regulatory guidance to support submission of high validity and relevance of real-world evidence …
Session Room 5A
A key question facing pre-commercial emerging pharma and biotech company leadership and directors…
Session Room 6F
While COVID-19 only first emerged in 2019, influenza has been plaguing humanity for centuries…
Session Room 8
3:30 PM - 4:30 PM (PDT)
Global health inequity has many dimensions, and strategies are needed to address each of these…
Session Room 2
Environmental, social, and governance (“ESG”) issues are gaining significant attention…
Session Room 7B
Tuesday, June 14
11:00 AM - 12:00 PM (PDT)
  Although specific aspects of clinical trials decentralization were in place before the…
Session Room 3
Our nation’s newborn screening system is a public health success but increasingly lags far…
Session Room 11A
As several new therapies originating in China begin reaching the review and regulatory approval…
Session Room 6D
Recent collaborations and financing deals involving small-mid biotechs and big pharmaceutical firms…
Session Room 6C
Patient advocacy organizations (PAOs) are increasingly offering sophisticated resources and…
Session Room 7B
BioSpace in collaboration with Russo Partners will present an interactive panel session focused on…
Session Room 2
Aging is the primary risk factor for many chronic conditions, and diseases of aging represent an…
Session Room 1B
The COVID-19 pandemic has been a catalyst for vaccine innovation, with both the development of…
Session Room 8
Emerging biotechs applying today’s revolutionary technologies face two interrelated questions…
Session Room 6F
1:45 PM - 2:45 PM (PDT)
The rare disease patient undergoes a diagnostic odyssey that takes five to eight years on average,…
Session Room 11A
Diagnostics and research tools are informing novel vaccine development like the COVID mRNA vaccines…
Session Room 8
  Enhancing diversity and inclusion in clinical studies is critical to closing the health…
Session Room 2
Strategic partnerships are critical for driving digital health innovation forward. Join us for an…
Session Room 4
2020 was the year of the SPAC – raising nearly double what was raised over the course of the…
Session Room 6D
Given a less than 8% likelihood for a New Drug Approval from first in man clinical trials, drug…
Session Room 3
1:45 PM - 3:00 PM (PDT)
The current pandemic has created a national discussion about the fragility of global supply chains…
Session Room 5B
3:00 PM - 4:00 PM (PDT)
The COVID-19 pandemic highlighted the need for more geographic diversity in the production…
Session Room 8
While chronic diseases often pose persistent, daily challenges, many patients have few treatment…
Session Room 1B
The challenge of health equity is common across healthcare systems, but it will require different…
Session Room 7B
Biotech brought the world innovation and cures and helped things get back to the new normal…
Session Room 6F
Join this panel of the leading investors in digital health to learn more about the 2022 investment…
Session Room 4
Economic marginalization can lead to gaps in access to healthcare and education, income disparities…
Session Room 2
The last 24 months has exposed unprecedented supply chain risks adversely impacting business…
Session Room 3
In recent times, the epigenetic drug discovery field has made substantial progress. So far,…
Session Room 6C
4:15 PM - 5:15 PM (PDT)
  The inescapable visibility of health inequalities during the COVID-19 pandemic has animated…
Session Room 3
Women leaders have become increasingly more prominent throughout biotech in recent years, and these…
Session Room 7B
Creating an equitable and inclusive biotech ecosystem that fosters participation of individuals…
Session Room 2
As efforts are underway to grow vaccine manufacturing capacity across the African continent,…
Session Room 8
The current stock market environment for small biotechs is tough even by historical standards. …
Session Room 6D
Now, the most critical assets of life sciences companies are data and information. They are virtual…
Session Room 4
Wednesday, June 15
11:00 AM - 12:00 PM (PDT)
There has been tremendous progress in advancing gene therapies and delivering these life-changing…
Session Room 2
  With a 90% failure rate and tens of billions in lost R&D costs every year, there is no…
Session Room 3
The urgency of the COVID-19 pandemic has accelerated the development, trial, and use of innovative…
Session Room 8
This panel of leading industry experts will discuss key considerations and experiences related to…
Session Room 1B
Protein degradation has emerged as one of the hottest areas of therapeutic research. Harnessing the…
Session Room 5A
Do you have what it takes to entice the industry’s top investors? Bring your A-game as you…
Session Room 6D
Healthy women and girls are the foundation for healthier societies. Investing in women's and girls'…
Session Room 5B
20 years ago, European pharmaceutical legislation was born, creating the continent’s single…
Session Room 7B
A discussion among panelists regarding the role of Big Data and AI at each stage of the drug…
Session Room 11A
  Prescription Digital Therapeutics (PDTs) present a novel opportunity for companies to…
Session Room 4
Until recently, there has been a consensus that the use of both accelerated approvals and surrogate…
Session Room 6C
Join some of Pharma’s biggest dealmakers as they discuss the challenges, opportunities, and…
Session Room 6F
1:45 PM - 2:45 PM (PDT)
Drug development remains a field defined by failure, with roughly 90% of products entering clinical…
Session Room 4
The value equation can be very different for patients with various conditions in different…
Session Room 6C
Diagnostic testing to identify patients who could benefit from targeted therapies is a cornerstone…
Session Room 3
Millions of people around the world are impacted by diseases of the brain — including…
Session Room 5B
Vaccines for COVID-19 were developed, produced and made available in developed countries in less…
Session Room 8
Executives can ignite change in the biotechnology ecosystem through strategic funding and company…
Session Room 5A
The panel will explore the question as to whether crossover rounds are still needed to enter the U…
Session Room 6F
3:00 PM - 4:00 PM (PDT)
The remarkable convergence of advances in bioengineering and neurology has resulted in a fast…
Session Room 5B
Over the past decade, the scientific community has delivered an impressive pace of scientific…
Session Room 7B
This session will focus on considerations for evaluating the comparability of cell and gene therapy…
Session Room 1B
Recent successes in genetic medicine (regulatory approvals of Zolgensma and Luxturna, for example)…
Session Room 2
Many Life Sciences companies have become ever reliant on global supply chains in order to source…
Session Room 6D
  Commercial space activity is on the rise with advances in technologies that are lowering…
Session Room 5A
  In 2021, cancer diagnostics achieved a long-discussed “Holy Grail” milestone…
Session Room 3
Modern medicine as we know it is threatened by antimicrobial resistance (AMR). From common…
Session Room 8
Current value-based arrangements don’t address the stakeholder at the center of the issue …
Session Room 6C
Traditional drug development has involved fleets of scientists in lab coats.  But with…
Session Room 11A
4:15 PM - 5:15 PM (PDT)
The identification of novel discoveries – ranging from cutting edge technologies to…
Session Room 3
Marwood Group estimates that there are more than 500 CDMOs globally and with more 45 large pharma…
Session Room 1B
Widespread evidence shows that cognitive problems are the second most commonly reported symptom …
Session Room 5B
Thursday, June 16
9:00 AM - 10:00 AM (PDT)
  Improvements in care benefit patients but make it harder to demonstrate survival gains in…
Session Room 6B
 Cellular therapies carry immense promise to provide treatment for previously unmet disease…
Session Room 2
Research universities are unparalleled generators of scientific knowledge and potentially impactful…
Session Room 3
The psychedelics industry has evolved from a stigmatized counterculture phenomenon to a…
Session Room 5B
10:15 AM - 11:15 AM (PDT)
New federal funding tools to support translational research and bio tech hubs are being developed…
Session Room 3
Many life sciences companies offer programs to help patients afford their medications. But how can…
Session Room 6C
During recent years, a few challenges and risks to patients have been reported emerging from viral…
Session Room 2
Not Yet Scheduled
Neurological disorders pose some of the greatest challenges and areas of unmet need in medicine…
Testing testing 123
Session Room 6B